Drawing for SPACEUTICALS

USPTO serial 76409555

SPACEUTICALS

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
SALEMI, DOMINICK
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SPACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Body and skin care products, namely, face and body lotions, face and body soaps, face and body creams, non-medicated skin care serums, skin toners, body and face masks, face and skin cleansers, face and skin exfoliators, and skin moisturizersABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 29, 2006ABN5ABANDONMENT - AFTER PUBLICATION—
Mar 28, 2006EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Sep 24, 2005EX5GSOU EXTENSION 5 GRANTED—
Sep 16, 2005EXT5SOU EXTENSION 5 FILED—
Sep 16, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 18, 2005EX4GSOU EXTENSION 4 GRANTED—
Mar 23, 2005EXT4SOU EXTENSION 4 FILED—
Mar 23, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 12, 2004CFITCASE FILE IN TICRS—
Aug 12, 2004CFITCASE FILE IN TICRS—
Aug 12, 2004CFITCASE FILE IN TICRS—
Aug 10, 2004EX3GSOU EXTENSION 3 GRANTED—
Aug 10, 2004EXT3SOU EXTENSION 3 FILED—
Aug 10, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 2, 2004EX2GSOU EXTENSION 2 GRANTED—
Feb 19, 2004EXT2SOU EXTENSION 2 FILED—
Feb 19, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 9, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 24, 2003EX1GSOU EXTENSION 1 GRANTED—
Sep 15, 2003EXT1SOU EXTENSION 1 FILED—
Sep 15, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 25, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 31, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 11, 2002NPUBNOTICE OF PUBLICATION—
Oct 25, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 23, 2002CNEAEXAMINER'S AMENDMENT MAILED—
Oct 18, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance